Recently Added Records

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset contains unsafe sanitation exposure estimates by year, location, age, sex, and primary toilet type for the years 1990-2021. Exposure to unsafe sanitation is defined based on the primary toilet type used. Toilet types include unimproved facilities (pit latrines without a slab, hanging or bucket latrines, and open defecation), and improved facilities (pit latrines with slabs, and composting toilets). Estimates include both the proportion of the population exposed and the number of individuals within the given population that are exposed. Estimates include mean, and the 95% uncertainty intervals. Only mean estimates are available for both sex.

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories.

This dataset provides annual estimates for the prevalence of overweight and obesity across various child and adolescent age groups from 1990 to 2021, with projections from 2022 to 2050. The estimates are based on data sources from the GBD 2021 analyses.

Researchers systematically reviewed literature on the health burden of physical violence, psychological violence, and neglect during childhood. Utilizing the Burden of Proof (BoP) methodology, a meta-analytical approach that generates conservative measures of association while accounting for heterogeneity between input studies, the authors summarized the relationship between these forms of violence against children and 35 adverse health outcomes. This dataset comprises: a list detailing all studies incorporated into our analysis; processed input data from each included study; and results for each exposure-outcome BoP analysis, including pooled relative risks and BoP-specific metrics (i.e., burden of proof risk function, risk-outcome score, and star rating).

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset includes estimates of the mean age of death, the fraction of suicide attempts (incident cases) to the number of deaths due to suicides, the ratio of incident cases to deaths, the number and percentage of suicide deaths that occurred from firearms, for males and females, globally and for each GBD region in 2021. The results also include a comparison of age-standardised mortality rate per 100,000 due to suicide by sex and region in 1990, 2019, and 2021. A variety of data were gathered to inform these estimates, including vital registration data, verbal autopsy data, and mortality surveillance data that included 23,782 study-location-years of data from GBD 2021.

Homicide and homicide due to firearm rate estimates were produced at the county level in the United States, and by racial and ethnic population, for each year between 2000-2019. These estimates were generated using population and deaths data from the National Center for Health Statistics.

This dataset includes the following:

• CSV files of county-, state-, and national-level estimates of homicide and firearm-related homicide rates for each age group, sex, year, and racial and ethnic population (non-Latino and non-Hispanic American Indian or Alaska Native [AIAN], non-Latino and non-Hispanic Asian or Pacific Islander [Asian], non-Latino and non-Hispanic Black [Black], Latino or Hispanic [Latino], and non-Latino and non-Hispanic White [White]). Blank cells are for masked estimates.
• Code used to generate the estimates.

Researchers systematically reviewed literature on the health burden of physical, sexual, and psychological gender-based violence impacting both men and women. Employing the Burden of Proof (BoP) methodology, a meta-analytical approach designed to produce conservative estimates of associations while heterogeneity between input studies analyzed, the researchers delineated the relationship between these forms of violence against men and women and eighth adverse health outcomes. Data were extracted and synthesized from 40 unique studies. This dataset includes: a comprehensive list of all the studies incorporated into our analysis; the processed input data from each study included; and the outcomes for each exposure-outcome analysis according to the Burden of Proof (BoP) methodology, including pooled relative risks and BoP-specific metrics (i.e., burden of proof risk function, risk-outcome score, and star rating).

Research by the IHME estimated malaria spending for 106 countries which were malaria-endemic over 2000-2020 or became malaria-free after 2000. These estimates cover malaria spending disaggregated by source into three domestic financing sources (government, out-of-pocket, and prepaid private) and development assistance for health (DAH). Government spending and DAH estimates are disaggregated by ten malaria program areas. Domestic spending estimates were produced from a diverse set of data, including National Malaria Control Programs, the WHO’s World Malaria Reports (WMRs), the WHO’s Global Health Expenditure Database (GHED), country spending estimates reported to the Pan American Health Organization (PAHO), country spending estimates reported to the Global Fund to Fight AIDS, Tuberculosis, and Malaria, and National Health Accounts (NHAs). Development Assistance for Malaria data were drawn from IHME’s 2021 Development Assistance for Health Database. Estimates are reported in constant 2021 USD.

This dataset contains estimates of the period lifetime probability of HIV acquisition, which quantifies the hypothetical probability of acquiring HIV for a “synthetic cohort”, a simulated population that is aged from birth to death through the set of age-specific incidence rates of a given time period. Using GBD 2021 HIV estimates, the prevalence of unsuppressed viraemia (PUV), which represents the proportion of the population without a suppressed level of HIV (viral load <1000 copies/mL) was also estimated.

Human Development Index (HDI) is a composite metric encompassing information about longevity, education, and income. HDI estimates were produced at an individual level and summarized at the population level by race and ethnicity, sex, age, and location. These estimates were generated using data from the American Community Survey and the National Vital Statistics System. Please refer to the Data Release Information Sheet for this dataset for more information on the estimates and input data included.

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories.

This dataset provides annual estimates for deaths and years of life lost (YLLs) for 2022-2050 in three smoking prevalence scenarios. Data sources used to produce the estimates came from GBD 2019 and GBD 2021 analyses.

Get YLL count data files
Get YLL rate data files

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset provides estimates for disability-adjusted life years (DALYs), years lived with disability (YLDs), years of life lost (YLLs), prevalence, and deaths for 37 individual conditions that impact the nervous system and aggregate health loss across all 37 conditions. Supplemental materials linked to the online publication describe data availability per condition.

Life expectancy estimates were produced in the United States between 2000-2021, for 10 mutually exclusive and collectively exhaustive Americas defined based on race and ethnicity, geographical location, metropolitan status, income and Black-White residential segregation, by sex, age group and year. These estimates were generated using population and deaths data from the National Center for Health Statistics.

This dataset includes the following:

• Estimates of life expectancy for each sex, age group, year and America
• Assignments of the Ten Americas classification for each combination of county and race and ethnicity
• Code used to generate the estimates

Development Assistance for Health (DAH) on COVID-19 produced estimates for 2020-2023, which are based on project databases, financial statements, annual reports, IRS 990s, and correspondence with agencies. The DAH Database enables comprehensive analysis of trends in international disbursements of grants and loans for COVID-19-related health projects in low- and middle-income countries from key agencies. The data are disaggregated by source of funds, channel of funding, country and geographic region, and program areas.

Cirrhosis mortality rate estimates were produced at the county level in the United States, by racial and ethnic population, for each year between 2000-2019. These estimates were generated using population and deaths data from the National Center for Health Statistics.

This dataset includes the following:

• CSV files of county-, state-, and national-level estimates of cirrhosis mortality rates for each age group, sex, year, and racial and ethnic population (non-Latino and non-Hispanic American Indian or Alaska Native [AIAN], non-Latino and non-Hispanic Asian or Pacific Islander [Asian], non-Latino and non-Hispanic Black [Black], Latino or Hispanic [Latino], and non-Latino and non-Hispanic White [White]). Blank cells are for masked estimates.
• Code used to generate the estimates.

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset provides air pollution exposure estimates for nitrogen dioxide pollution, ozone pollution, ambient particulate matter pollution, and household air pollution. Population-weighted exposure summary files are provided for all air pollution risk factors, and gridded exposure files are provided for nitrogen dioxide, ozone, and ambient particulate matter pollution. Also provided are estimates for relative risks due to exposure to particulate matter for ischemic heart disease, stroke, chronic obstructive pulmonary disease, lung cancer, acute lower respiratory infection, type 2 diabetes mellitus, as well as gestational age shifts.

Researchers at IHME and the London School of Hygiene and Tropical Medicine (LSHTM) conducted a systematic review and bias assessment of all primary data on measles seroprevalence in low- and middle-income countries published from 1962-2021. 

The Global Burden of Disease Study 2019 coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations. The Global Burden of Antimicrobial Resistance (GRAM) estimates the burden of pathogens, infectious syndromes and antimicrobial resistance.

This dataset includes disability-adjusted life-years (DALYs) associated with 85 pathogens in 2019, globally, regionally, and for 204 countries and territories.

Research by the Global Burden of Disease Health Financing Collaborator Network produced estimates for Gross Domestic Product (GDP) from 1960-2050. Estimates are reported as GDP per person in constant 2022 purchasing-power parity-adjusted (PPP) dollars. 

Research by the Global Burden of Disease Health Financing Collaborator Network produced projected health spending estimates for 2022-2050 for 204 countries and territories. The estimates cover total health spending, health spending disaggregated by source into three domestic financing source categories (government, out-of-pocket, and prepaid private), and development assistance for health (DAH). Retrospective health spending estimates for 1995-2022 and key covariates (including GDP per capita, total government spending, total fertility rate, and fraction of the population older than 65 years) were used to forecast GDP and health spending through 2050. Estimates are reported in constant 2022 US dollars, constant 2022 purchasing-power parity-adjusted (PPP) dollars, and as a percent of gross domestic product.

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

Annual estimates for deaths, DALYs, YLLs, and YLDs attributable to 88 risk factors, as well as estimates for summary exposure values (SEVs) by risk, are available from the GBD Results Tool. Estimates are available by age and sex for 1990-2021. Select tables and a supplementary results appendix published in The Lancet in May 2024 in "Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021" are also available for download via the link below.

This dataset contains retrospective estimates for the cost of informal care attributable to dementia in the United States of America from 2010 to 2019 and prospective cost estimates in 2030, 2040, and 2050 under both low and high growth scenarios. Retrospective estimates are provided for the US national level, each US state, and the District of Columbia. Prospective estimates are provided for the US national level only. Final estimates include both the replacement and forgone wage costs attributable to dementia per dementia case. The replacement cost model estimates how much it would cost to replace all informal caregiving with formal, paid caregivers. The forgone wage cost model estimates how much income is lost for informal caregivers by caring for a person living with dementia instead of working for a wage. All cost estimates are reported in 2019 United States dollars.

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This dataset provides annual estimates for age-specific fertility rate (ASFR), total fertility fate (TFR) and live births for 1950-2100. Data sources used to produce the estimates came from 8709 country-years of vital and sample registrations, 1455 surveys and censuses, and 150 other sources.

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

Annual estimates for fertility, population, migration, and all-cause mortality will be available from the GBD 2021 Results Tool (forthcoming May 2024). Estimates will be available by age and sex for 1950-2021. Select tables published in The Lancet in March 2024 in "Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021" are also available for download via the “Files” tab above.

The Global Burden of Disease Study 2021 (GBD 2021), coordinated by the Institute for Health Metrics and Evaluation (IHME), estimated the burden of diseases, injuries, and risk factors for 204 countries and territories and selected subnational locations.

This set of files contain the following for GBD 2021: the cause hierarchy; the risk, impairment, etiology, and injury n-code (REI) hierarchy; and locations hierarchies. The GBD Locations Hierarchy file contains only GBD locations, including subnational locations for which results were released at the time of the study's publication. The All Locations Hierarchies file also includes hierarchies for other regions for which estimates were produced, such as WHO and World Bank regions. These files allow users to filter for sets of values by level or parent category, including cause or risk group, GBD super region or region, or custom region.